CannPal Begins Phase 2 Pilot Study for Cannabis-Derived Osteoarthritis Drug for Dogs

Animal health company CannPal Animal Therapeutics Limited (ASX:CP1) recently announced the commencement of a Phase 2A pilot dose determination study for the company’s lead drug candidate, CPAT-01, in development for pain and inflammation control in dogs. The clinical trial is an 8 week randomized, double-blind, placebo-controlled study to assess theRead More →

U.S. Congress Seeks to Expand CBD and Medical Marijuana Research

On June 27, 2019, Senators Dianne Feinstein (D-Calif.), Chuck Grassley (R-Iowa), and Brian Schatz (D-Hawaii) co-sponsored the Cannabidiol and Marijuana Research Expansion Act. Backed by the American Medical Association (AMA), this bipartisan bill helps bolster scientific research into marijuana and cannabidiol (CBD), one of active compounds in the cannabis plant.Read More →

Ancient Humans of Glaciated Western China Consumed High-Potency Cannabis (Glacier Hub)

Via Glacier Hub: Evidence of marijuana use is scattered throughout the archaeological record of human civilization. Residue from most of those excavation sites indicates that the cannabis used by ancient humans was of too low potency to make any determination about its cultivation. This finding has led archaeologists to concludeRead More →

London Free Press: Western University studies using cannabis can lead to bad trips for some people.

Via the London Free Press: Neuroscientist Steven Laviolette and post-doctoral fellow Christopher Norris from the Schulich School of Medicine and Dentistry mapped how different regions of the brain produce significantly different reactions to marijuana use. The research shows some pot users experience highly rewarding effects, which could lead to dependence,Read More →